✦ LIBER ✦

Phase II multi-institutional study of Irinotecan (CPT-11) and Cisplatin (CDDP) on a three-week schedule in patients with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Cardenal, F.; Domine, M.; Massuti, B.; Felip, E.; Carrato, A.; Garrido, P.; Alberola, V.; Antón, A.; Barneto, I.; Rosell, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of an intensive single do

✍ Dómine, M; Cardenal, F; Massuti, B; Carrato, A; Felip, E; Garrido, P; Juan, O; A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase I study of irinotecan (CPT-11) and

✍ Kakolyris, S; Kouroussis, C; Souglakos, J; Androulakis, N; Mavroudis, D; Kalbaki 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Three-week schedule of irinotecan and ci

✍ Cardenal, F 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 120 KB

54 Phase I study of irinotecan (CPT-11)

✍ Hibino, S.; Kobayashi, K.; Takeda, Y.; Shinbara, A.; Kudoh, K.; Kabe, J.; Yoshim 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Fractionated administration of cisplatin

✍ Takata, I; Ueoka, H; Kiura, K; Hiraki, S; Eguchi, K; Okimoto, N; Harita, S; Yone 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Phase I study of irinotecan (CPT-11) and

✍ Nakamura, Y; Fukuda, M; Fukuda, Mi; Soda, H; Ichiki, M; Takatani, H; Kanda, T; K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB